Rocket Pharmaceuticals, Inc. faces class action lawsuit, Levi & Korsinsky issues reminder

Investors who purchased RCKT shares between May 7, 2022, and June 25, 2025, have until August 11, 2025, to participate in a class-action lawsuit. The lawsuit alleges that RCKT violated federal securities laws by misrepresenting and omitting key information that caused investors to suffer financial losses.

RCKT, a clinical-stage biopharmaceutical company, focuses on developing drugs for the treatment of serious diseases. However, the lawsuit claims that the company made false and misleading statements about the success of its drug trials and the prospects for obtaining regulatory approval. These alleged misrepresentations artificially inflated the price of RCKT stock, leading investors to purchase shares at artificially inflated prices.

The class-action lawsuit further alleges that RCKT failed to disclose critical information regarding the drug’s safety and efficacy, which would have been essential for investors to make informed decisions. As a result, when the truth about the drug trials became public, RCKT’s stock price plummeted, causing investors significant financial harm.

Investors who wish to participate in the class-action lawsuit must meet certain criteria and deadlines. They must have purchased RCKT shares during the specified time period and have suffered financial losses as a result of the alleged misrepresentations. These investors have until August 11, 2025, to seek appointment as lead plaintiff in the lawsuit.

It is essential for investors to take action before the deadline to ensure they have the opportunity to recover any losses incurred due to RCKT’s alleged misconduct. By participating in the class-action lawsuit, investors can seek to hold RCKT accountable for its actions and potentially recover damages.

Levi & Korsinsky, the law firm representing the plaintiffs in the class-action lawsuit, is committed to advocating for investors who have been harmed by securities fraud. The firm has a strong track record of successfully litigating similar cases and has the resources and expertise to pursue a favorable outcome for investors in this case.

Investors who believe they may be eligible to participate in the class-action lawsuit are encouraged to contact Levi & Korsinsky before the August 11, 2025, deadline. By taking action and seeking to hold RCKT accountable for its alleged misconduct, investors can work towards obtaining a fair resolution to their financial losses.